a CL <10mm. We examined the progression of women based on the CL measurement and GA at diagnosis. The primary outcome was cervical dilation or spontaneous delivery <24 weeks. Chi square and logistic regression analysis was used. RESULTS: A total 163 women were included, of whom 27 (16.6%) were ultimately dilated and 4 (2.5%) had pregnancy loss by 24 weeks. The median GA at diagnosis of short CL was 19 5/7 (range 15-22) weeks. Women with a CL 15 were more likely to have dilation or pregnancy loss prior to 24 weeks than women whose CL was 16-25mm (42.5% vs. 11.9%, <0.001). GA at diagnosis was not associated with risk of progression. After controlling for differences in baseline characteristics including GA at short CL diagnosis, in vitro fertilization, and history of cervical cone biopsy or loop electrosurgical excision procedure, CL 15mm was independently associated with almost a 4-fold increase in odds of dilation or loss (aOR 3.72, 95% CI 1.52-9.09). CONCLUSION: In women with a short CL without a history of SPTB, the risk of dilation or pregnancy loss <24 weeks is significant, approaching 50% for women with a CL 15mm. This supports the practice of serial CL measurements in women found to have a short cervix, especially with a CL 15mm, in order to identify those who may become dilated and potentially benefit from an exam-indicated cerclage.
559 First trimester MMP-8 profiles vary among women who smoke cigarettes, electronic-cigarettes and cannabis University of Kentucky, Lexington, KS OBJECTIVE: Prenatal exposures to tobacco smoke, e-cigarette (ecig) vapor, and cannabis smoke is increasing and are more frequent in women with depressive symptoms, anxiety, and/or stress. We have previously demonstrated the inflammatory milieu is altered in populations at risk for preterm birth, with these exposures, and in women with objective assessments for stress as early as the first trimester. The purpose of the present evaluation was to assess the first trimester inflammatory profile in women with differing prenatal exposures. STUDY DESIGN: A cross-sectional examination in a prospective study was conducted with 101 pregnant women with tobacco use in their first trimester. Cannabis use was validated via measurement of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in a urine sample, while tobacco use was confirmed via preset urinary cotinine limits. Ecig use was noted per maternal self-report. Multiple serum inflammatory markers were measured including interleukins (ILs) 1a, 1b, 2, 4, 6, 8, 10, TNFa, and matrix metalloproteinase (MMP) 8. Data analysis included descriptive statistics, univariate and multivariate analysis. RESULTS: The study cohort (n¼101) included 52 women who smoked tobacco only, 20 women with e-cig and conventional tobacco use, in addition to 29 women with conventional tobacco and cannabis use. Similar to past studies in women with stress, the only inflammatory marker demonstrating significant variation between groups was MMP-8. The median concentration of MMP-8 was 22.5 ng/ml (7.6-159.2 ng/ml) in the co-cannabis users, 35.2 ng/ml (6.5-124 ng/ml) in the tobacco only group, and highest among ecig cousers 51.9 ng/ml (15.6-190.5 ng/mL). After controlling for age and BMI this significant difference persisted. (F¼5.2, P¼.007). MMP-8 levels were significantly higher among women using e-cigarettes compared to both cigarette only, P¼.017, and cannabis plus tobacco users P¼.002. CONCLUSION: Serum MMP-8 again demonstrated variation in populations at risk for adverse events. Women with differing exposures during the first trimester have differences in inflammatory profiles with ecig use demonstrating a concerning increase in MMP-8 concentration worthy of further investigation. 
OBJECTIVE:
The cervix functions as a physical and biochemical barrier to ascending pathogens in pregnancy. Short cervical length is a major risk factor for spontaneous preterm birth (sPTB). While the lack of lactobacillus species has been associated with an increased risk of sPTB, the relationship between cervicovaginal (CV) microbial communities and cervical length is unknown. We sought to examine the association between CV microbial communities and short cervix. STUDY DESIGN: This was a secondary analysis of a pregnancy cohort study, "Motherhood and Microbiome." Cervical swabs were collected at 16-20 weeks' gestation and cervical length was measured by transvaginal ultrasound at the time of the level 2 ultrasound (mean 20 weeks). We analyzed the CV microbiota with 16S rRNA sequencing and classified microbial communities into CSTs as previously reported (Ravel et al. PNAS 2011) . CST IV is characterized by a preponderance of anaerobes and paucity of lactobacillus species. In women with cervical length measured, CV microbial data were available on 67 sPTBs, 47 medically-indicated PTBs (mPTBs), and 358 term births. We used log-binomial regression to model associations of CST IV and short cervix (<25 mm) and calculate adjusted risk ratios (aRR). RESULTS: Mean cervical length was 34.6 mm, 34.3 mm, and 26.2 mm among term births, mPTBs, and sPTBs, respectively (p<0.0001) and did not differ significantly among women with CST IV versus all other women (32.9 mm and 33.6 mm respectively, p¼0.3); however, the prevalence of a short cervix was significantly higher (11.3% compared to 6.1%, p¼0.04). After adjusting for race/ethnicity, body mass index, insurance status, and prior sPTB, women with CST IV had higher risk of short cervix (aRR 1.9, CI: 1.03-3.6). CONCLUSION: CST IV, which is characterized by anaerobes and a paucity of lactobacillus species, is associated with increased risk of short cervix during pregnancy, a major risk factor for sPTB. Determining the cascade of events that lead to premature cervical remodeling, potentially including dysbiosis, could be critical in preventing sPTB (R01NR014784; ME).
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OBJECTIVE: To determine whether the risk of intra-amniotic infection, intra-amniotic inflammation, and spontaneous preterm delivery varies as a function of the concentration of cervical fetal fibronectin in patients presenting with preterm labor and intact membranes. STUDY DESIGN: This was a prospective study in which patients with preterm labor and intact membranes had a sample collected for quantitative cervical fetal fibronection at the time of admission. Patients underwent amniocentesis for the assessment of the microbial state of amniotic cavity. Amniotic fluid was cultured for aerobic and anaerobic bacteria and for genital mycoplasmas. Intra-amniotic inflammation was defined as an elevated amniotic fluid matrix metalloproteinase-8 (MMP-8) concentration (> 23 ng/mL). The quantitative fetal fibronectin concentration in cervical secretions was determined with a commercially available enzyme-linked immunosorbent assay. Nonparametric tests and survival techniques were used for analysis. RESULTS: A total of 180 patients were enrolled in the study. 1) The prevalence of intra-amniotic infection, intra-amniotic inflammation, the combination of intra-amniotic infection or inflammation and spontaneous preterm delivery within 7 days were 7.3% (13/179), 30% (54/180), 32.2% (58/180) and 33.9% (61/178), respectively; 2) The higher the fetal fibronectin concentration, the greater the risk of intra-amniotic infection, intra-amniotic inflammtion, intraamniotic infection and/or inflammation and spontaneous preterm delivery within 7 days (P<0.005 for intra-amniotic infection and P<0.001 for intra-amniotic inflammation and infection and/or inflammation); 3) A high concentration of fetal fibronectin in cervical fluid was associated with spontaneous preterm delivery within 7 days and 14 days only in patients without intra-amniotic infection and/or inflammation; 4) Among the patients with a fetal fibronectin < 50 ng/mL, intra-amniotic infection and/or inflammation was identified in 7.6% (6/79) of patients and 66.7 % (4/6) delivered within 7 days of amniocentesis. CONCLUSION: 1) the higher the concentration of cervical fetal fibronectin, the greater the risk of intra-amniotic infection and/or inflammation and spontaneous preterm delivery in patients with preterm labor and intact membranes; 2) Intra-amniotic infection and/or inflammation was identified in 7.6% of patients with a fetal fibronectin concentration of lower than 50 ng/ml. 
